Back to Studies

IMPAACT 2028

Long-Term Clinical, Immunologic, and Virologic Profiles of Children who Received Early Treatment for HIV

Study Status

Pending

DAIDS Number

38693

IND Number

NA

Clinical Trials Link

Summary

IMPAACT 2028 is an observational study to characterize a cohort of children who may participate in future research related to HIV remission or cure. Children in this study will have previously received early or very early treatment for HIV in other IMPAACT studies or other studies sponsored by the United States National Institutes of Health. Children in this study will complete study visits approximately every six months at which key clinical, immunologic, and virologic outcomes will be assessed for a period of up to seven years.

Loading study documents...
Loading study sites...
Loading study protocol team...
Loading study press...
Loading study publications/presentations...